Nordicus Partners Corp. Files Q1 2025 10-Q
Ticker: NORD · Form: 10-Q · Filed: Aug 19, 2024 · CIK: 1011060
Sentiment: neutral
Topics: 10-Q, financials, management-consulting
TL;DR
Nordicus Partners Corp. 10-Q filed. Financials for Q1 2025 out.
AI Summary
Nordicus Partners Corp. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the company, which operates in the management consulting services sector. Specific financial figures and operational highlights are presented within the report.
Why It Matters
This filing provides investors and analysts with the latest financial health and strategic direction of Nordicus Partners Corp., crucial for understanding its market position and future prospects.
Risk Assessment
Risk Level: low — This is a standard quarterly filing providing financial information, not indicating immediate operational or financial distress.
Key Numbers
- 2024-06-30 — Reporting Period End Date (Indicates the end of the fiscal quarter for which financial data is reported.)
- 2024-08-19 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
- 0331 — Fiscal Year End (The company's fiscal year concludes on March 31st.)
Key Players & Entities
- Nordicus Partners Corp. (company) — Filer of the 10-Q
- 20240630 (date) — End of the reporting period
- 8742 (number) — Standard Industrial Classification code for Management Consulting Services
- 280 SOUTH BEVERLY DR. SUITE 505 (address) — Company's business and mailing address
- BEVERLY HILLS, CA 90212 (address) — Company's business and mailing address city, state, zip
- 508-523-3141 (phone_number) — Company's business phone number
- EKIMAS Corp (company) — Former company name
- AdvanSource Biomaterials Corp (company) — Former company name
- CARDIOTECH INTERNATIONAL INC (company) — Former company name
FAQ
What is the primary business of Nordicus Partners Corp.?
Nordicus Partners Corp. operates in the SERVICES-MANAGEMENT CONSULTING SERVICES sector, with SIC code 8742.
What is the address of Nordicus Partners Corp.?
The company's business and mailing address is 280 SOUTH BEVERLY DR., SUITE 505, BEVERLY HILLS, CA 90212.
When does Nordicus Partners Corp.'s fiscal year end?
The company's fiscal year ends on March 31st.
What period does this 10-Q filing cover?
This 10-Q filing covers the period ending June 30, 2024.
Has Nordicus Partners Corp. operated under different names previously?
Yes, the company has previously operated under the names EKIMAS Corp, AdvanSource Biomaterials Corp, and CARDIOTECH INTERNATIONAL INC.
Filing Stats: 4,560 words · 18 min read · ~15 pages · Grade level 15.5 · Accepted 2024-08-19 17:30:45
Key Financial Figures
- $0.001 — Section 12(g) of the Act: Common Stock, $0.001 par value per share Indicate by check
Filing Documents
- form10-q.htm (10-Q) — 463KB
- ex31-1.htm (EX-31.1) — 11KB
- ex31-2.htm (EX-31.2) — 11KB
- ex32-1.htm (EX-32.1) — 11KB
- 0001493152-24-033179.txt ( ) — 2880KB
- nord-20240630.xsd (EX-101.SCH) — 24KB
- nord-20240630_cal.xml (EX-101.CAL) — 34KB
- nord-20240630_def.xml (EX-101.DEF) — 120KB
- nord-20240630_lab.xml (EX-101.LAB) — 217KB
- nord-20240630_pre.xml (EX-101.PRE) — 180KB
- form10-q_htm.xml (XML) — 289KB
Notes to Consolidated Financial Statements (unaudited)
Notes to Consolidated Financial Statements (unaudited) 7 Item 2
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 13 Item 3
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 16 Item 4
Controls and Procedures
Controls and Procedures 16 PART II OTHER INFORMATION 16 Item 1.
Legal Proceedings
Legal Proceedings 16 Item 1A.
Risk Factors
Risk Factors 16 Item 2 Unregistered Sales of Equity Securities and Use of Proceeds 16 Item 3 Defaults Upon Senior Securities 16 Item 4 Mine Safety Disclosures 17 Item 5 Other Information 17 Item 6 Exhibits 17
Signatures
Signatures 18 2 PART I - FINANCIAL INFORMATION Item 1. Unaudited Financial Statements NORDICUS PARTNERS CORPORATION AND SUBSIDIARY CONSOLIDATED BALANCE SHEETS June 30, 2024 March 31, 2024 (Unaudited) ASSETS Current assets: Cash $ 26,726 $ 49,933 Prepaids and other current assets 53,627 — Total current assets 80,353 49,933 Website 10,940 7,640 Other assets 317,511 — Goodwill 18,641,985 — Investment in Mag Mile Capital, Inc. 1,750,000 1,750,000 Total Assets $ 20,800,789 $ 1,807,573 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable and accrued expenses $ 65,155 $ 5,019 Deferred revenue — 7,500 Related party payable — 13,886 Total current liabilities 65,155 26,405 Total Liabilities 65,155 26,405 Commitments and contingencies — — Stockholders' equity: Preferred stock; $ 0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding — — Common stock; $ 0.001 par value; 50,000,000 shares authorized; 49,465,276 and 11,102,248 shares issued; respectively 49,462 11,102 Treasury stock, 1,534 shares at cost ( 30,328 ) ( 30,328 ) Additional paid-in capital 63,911,274 45,686,769 Accumulated other comprehensive income ( 3,078 ) ( 2,848 ) Accumulated deficit ( 44,141,696 ) ( 43,883,527 ) Total equity attributed to the parent 19,785,634 1,781,168 Non-controlling interest 950,000 — Total stockholders' equity 20,735,634 1,781,168 Total liabilities and stockholders' equity $ 20,800,789 $ 1,807,573 The accompanying notes are an integral part of these unaudited consolidated financial statements. 3 NORDICUS PARTNERS CORPORATION AND SUBSIDIARY CONSOLIDATED (Unaudited) 2024 2023 For the Three Months Ended June 30, 2024 2023 Revenue $ — $ — Operating expenses: Officer compensation 49,442 27,000 Professional fees 25,782 19,925 Consulting expense 150,000 — General a